Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

BACKGROUND: To assess the feasibility and early toxicity of selective, IMRT-based dose escalation (simultaneous integrated boost) to biopsy proven dominant intra-prostatic lesions visible on MRI. METHODS: Patients with localized prostate cancer and an abnormality within the prostate on endorectal co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Singh, Anurag K, Guion, Peter, Sears-Crouse, Nancy, Ullman, Karen, Smith, Sharon, Albert, Paul S, Fichtinger, Gabor, Choyke, Peter L, Xu, Sheng, Kruecker, Jochen, Wood, Bradford J, Krieger, Axel, Ning, Holly
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2007
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075521/
https://ncbi.nlm.nih.gov/pubmed/17877821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-2-36
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia